Sponsor or institution

Clinical trials and research at Fundación EPIC

• 19Clinical trials
• 10Countries

Newest trials

All recruiting trials (19)

• Hydra THV Transfemoral Valve Implantation in Severe Aortic Stenosis

  This registry tests how safely and effectively the Hydra THV works when implanted through the femoral artery in adults with severe symptomatic aortic stenosis.

  Recruiting at 8 sites Fundación EPIC · Aravaca and 7 other locations · NCT07566624

• LONG NAGOMI PMCF: follow-up of the Ultimaster Nagomi stent in long coronary artery lesions

  This project tests the Ultimaster Nagomi drug-eluting stent in adults undergoing PCI for long coronary lesions to collect real-world safety and effectiveness data.

  Recruiting at 10 sites Fundación EPIC · Cabueñes and 9 other locations · NCT07399002

• Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease

  This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.

  Recruiting at 10 sites Fundación EPIC · Boston, Massachusetts and 14 other locations · NCT07286578

• Amulet vs LAmbre: Left Atrial Appendage Closure in NVAF patients at high bleeding risk

  This study tests whether the Amplatzer Amulet or the LAmbre device works better for closing the left atrial appendage in adults with non-valvular atrial fibrillation who are at high risk of stroke and bleeding.

  Recruiting Fundación EPIC · Fuencarral-El Pardo · NCT07260474

• SELUTION sirolimus-eluting balloon for treating coronary artery blockages and in-stent restenosis

  This registry will try the SELUTION sirolimus-coated balloon in adults with coronary artery disease—including native vessel blockages and in-stent restenosis—to see how safe and effective it is in routine clinical practice.

  Recruiting at 16 sites Fundación EPIC · Amadora and 15 other locations · NCT07256249

• ihtDEStiny® versus Xience™ drug-eluting stents for acute coronary syndrome

  We will see if the ihtDEStiny® sirolimus-eluting stent works as well as the Xience™ everolimus-eluting stent in adults with acute coronary syndrome who need PCI.

  Recruiting at 20 sites Fundación EPIC · Alicante and 19 other locations · NCT07190690

• Ultrathin strut stent for patients on blood thinners

  This study is testing a new type of stent for patients on blood thinners to see if it can safely reduce the time they need to take additional blood-thinning medication after heart procedures.

  Recruiting at 13 sites Fundación EPIC · Albacete and 12 other locations · NCT06863155

• Orbital atherectomy versus standard balloon strategy for calcified coronary bifurcation lesions

  This study tests whether using orbital atherectomy before stenting helps adults with moderately or severely calcified coronary bifurcation lesions get better stent results than the standard balloon-first approach.

  Recruiting at 9 sites Fundación EPIC · Alicante and 8 other locations · NCT06736899

• Comparing drug eluting balloons and stents for treating calcified nodules in coronary arteries

  This study is testing whether drug eluting balloons can work as well as drug eluting stents for treating calcified nodules in the coronary arteries of patients with heart conditions.

  Recruiting at 15 sites Fundación EPIC · Leiden and 14 other locations · NCT06657833

• Impact of Calcium on Stent Healing in Coronary Artery Disease

  This study tests how the presence of calcium affects the healing of stents in patients with coronary artery disease to see if it makes a difference in recovery.

  Recruiting Fundación EPIC · Barcelona · NCT06631755

• Essential Pro paclitaxel‑eluting coronary balloon post-market follow-up (rEPIC04E-HK)

  This project will follow people with coronary artery disease treated with the Essential Pro paclitaxel‑eluting coronary balloon to see if the device is safe and works well in routine care.

  Recruiting Fundación EPIC · Lai Chi Kok · NCT06631157

• Evaluating short-term antiplatelet therapy after heart procedure for atrial fibrillation

  This study is testing if a short-term treatment with either aspirin or clopidogrel can safely help people with atrial fibrillation who can't take long-term blood thinners after a heart procedure to prevent strokes.

  Recruiting at 22 sites Fundación EPIC · A Coruña and 21 other locations · NCT06620757

• Comparing drug-coated balloons and drug-eluting stents for coronary artery disease

  This study is testing whether a special balloon or a stent works better to improve blood flow in people with coronary artery disease after eight months.

  Recruiting at 9 sites Fundación EPIC · Barcelona and 8 other locations · NCT06448637

• Evaluating new methods for assessing coronary artery disease after procedures

  This study is testing a new way to check for coronary artery disease in patients with multiple blocked arteries to see if it works better than the usual method after they have heart procedures.

  Recruiting at 4 sites Fundación EPIC · Alicante and 3 other locations · NCT06273293

• Comparing two types of transcatheter aortic valves for patients with valve deterioration

  This study is testing which of two types of heart valves works better for patients who need a replacement due to valve problems.

  Recruiting at 12 sites Fundación EPIC · Alessandria and 11 other locations · NCT06049654

• Using two stent retrievers at once versus one for treating acute ischemic stroke

  We will test whether using two stent retrievers at the same time helps people with acute ischemic stroke get their blocked artery opened faster and recover better during mechanical thrombectomy.

  Recruiting at 4 sites Fundación EPIC · Essen and 3 other locations · NCT05930145

• Post-market follow-up of Coroflex® ISAR NEO coronary stent system

  This study is testing how safe and effective the Coroflex® ISAR NEO stent is for patients who need it in real-life situations.

  Recruiting at 26 sites Fundación EPIC · Aix-en-Provence and 25 other locations · NCT05698732

• Post-market follow-up for the SUPRAFLEX CRUZ stent in patients with coronary artery disease

  This study is testing how well the SUPRAFLEX CRUZ stent works and if it's safe for people with coronary artery disease who are getting treated in real-life hospital settings.

  Recruiting at 21 sites Fundación EPIC · Elche, Alicante and 20 other locations · NCT05617599

• Evaluating a polypill for managing coronary risk factors

  This study tests if a combined pill with three heart medications can help people with coronary artery disease manage their blood pressure and cholesterol better than taking the medications separately.

  Recruiting Phase 4 Fundación EPIC · Gijón, Principality of Asturias · NCT05030818

Quick answers

How many clinical trials run by Fundación EPIC are recruiting right now?

19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in Spain (18 trials), United Kingdom (3 trials), Netherlands (1 trial), Belgium (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →